JANDROT-PERRUS; Martine

Patent Applications and Registrations

Patent applications and USPTO patent grants for JANDROT-PERRUS; Martine.The latest application filed is for "novel anti-human gpvi antibodies and uses thereof".

Company Profile

3.10.13

JANDROT-PERRUS; Martine - Vanves FR
JANDROT-PERRUS; Martine - Paris FR
Jandrot-Perrus; Martine - Paris Cedex N/A FR
Jandrot-Perrus; Martine - Paris Cedex 18 FR
Jandrot-Perrus; Martine - Vanes FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Anti-human Gpvi Antibodies And Uses Thereof App 20200384106 - BILLIALD; Philippe ; et al.	2020-12-10
Anti-human GPVI antibodies and uses thereof Grant 10,842,870 - Billiald , et al. November 24, 2	2020-11-24
Pharmaceutical Compositions For The Treatment Of Thrombosis In Patients Suffering From A Myeloproliferative Neoplasm App 20200087403 - JAMES; Chloe ; et al.	2020-03-19
Inhibition Of Platelet Aggregation Using Anti-human Gpvi Antibodies App 20190367608 - BILLIALD; Philippe ; et al.	2019-12-05
Novel Anti-human Gpvi Antibodies And Uses Thereof App 20180236071 - BILLIALD; Philippe ; et al.	2018-08-23
Aminofucoidan as a vector for fibrinolysis in thrombotic diseases Grant 9,999,679 - Loyau , et al. June 19, 2	2018-06-19
Aminofucoidan As A Vector For Fibrinolysis In Thrombotic Diseases App 20160279249 - LOYAU; Stephane ; et al.	2016-09-29
Anti-glycoprotein VI scFv fragment for treatment of thrombosis Grant 9,045,538 - Jandrot-Perrus , et al. June 2, 2	2015-06-02
Anti-glycoprotein VI scFv fragment for treatment of thrombosis Grant 9,045,540 - Jandrot-Perrus , et al. June 2, 2	2015-06-02
Method and kits for determining platelet susceptibility to activation in a patient Grant 9,029,095 - Jandrot-Perrus , et al. May 12, 2	2015-05-12
Method And Kits For Determining Platelet Susceptibility To Activation In A Patient App 20130310401 - Jandrot-Perrus; Martine ; et al.	2013-11-21
Anti-glycoprotein Vi Scfv Fragment For Treatment Of Thrombosis App 20130189259 - Jandrot-Perrus; Martine ; et al.	2013-07-25
Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis Grant 8,466,258 - Jandrot-Perrus , et al. June 18, 2	2013-06-18
Anti-glycoptrotein Vi Scfv Fragment For Treatment Of Thrombosis App 20110182899 - Jandrot-Perrus; Martine ; et al.	2011-07-28
Polypeptides, Cyclic Polypeptides and Pharmaceutical Comprising Thereof for Non Invasive Specific Imaging of Fibrosis App 20100303724 - Jandrot-Perrus; Martine ; et al.	2010-12-02
Glycoprotein VI and Uses Thereof App 20100261200 - Busfield; Samantha J. ; et al.	2010-10-14
Glycoprotein VI and uses thereof App 20060216291 - Busfield; Samantha J. ; et al.	2006-09-28
Glycoprotein VI antibodies and uses thereof Grant 6,989,144 - Busfield , et al. January 24, 2	2006-01-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.